Chief Medical Officers In Biotechs Finally Have Their Own Conference, 6-7 May 2013, Boston, MA

news headlines

email to a friend

printer friendly

Chief Medical Officers In Biotechs Finally Have Their Own Conference, 6-7 May 2013, Boston, MA

Main Category: Conferences

Article Date: 19 Mar 2013

For the first time, Chief Medical Officers at biotechs will have their own conference thanks to the idea from Dr Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the organizer of the event says, "We are grateful to Dr Stoner's idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs."

The Chief Medical Officer Summit takes place in Boston on May 6-7, 2013 and is dedicated to accomplishing two goals:

To bring together CMO executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital, working and meeting with investors and strategsing for appropriate exits.  
To create a network of CMOs from small to mid size life science companies to share ideas, solutions and support.

Dr Steven Zelenkofske, CMO & SVP Clinical and Medical Affairs, Regado Biosciences and advisor to the program remarked, "I am excited about this conference and think it is very much needed."

Event Details: May 6-7, Boston, MA  The event organizers are offering a 10% discount with code CMOE and a pre-early bird rate before 3/1. Click here to register.

Program Overview and Agenda are available at http://www.theconferenceforum.org.  Questions, please email service(at)theconferenceforum(dot)org

Speaking Faculty:
 Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH  
Mark Corrigan, MD, President & CEO, Zalicus
 Anthony Coyle, PhD, VP & CSO, Centers for Therapeutic Innovation, Pfizer  
Daniel Curran, MD, VP, Corporate Development, Millennium, Takeda Oncology  
Greg Fiore, MD, CMO, The Medicines Company  
Ken Getz, MBA, Senior Research Fellow, Tufts
 Sheila Gujrathi, MD, CMO, Receptos  
M. Scott Harris, MD, CMO, Avaxia Biologics; Principal, Middleburg Consultants; and Clinical Professor of Medicine, Georgetown University School of Medicine  
Eric Hedrick, MD, CMO, Epizyme
Karin Hehenberger, MD, PhD, Executive Vice President & CMO, Coronado Biosciences  
Dennis Kim, MD, MBA, CMO, Zafgen  
Chris Kiritsy, MBA, President & CEO, Arisaph  
Lori Kunkel, MD, CMO, Pharmacyclics
 Tyler Martin, MD, President, CMO & Director, Dynavax Technologies  
Robert Pyke, MD, PhD, CMO, S1 Biopharma  
Jim Roach, MD, CMO & Senior Vice President, Development, Momenta Pharmaceuticals  
Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
 Jeffrey Sherman, MD, FACP, CMO & Executive Vice President, Development, Manufacturing, and Regulatory Affairs, Horizon Pharma  
Greg Simon, CEO, Poliwogg  
Elizabeth Stoner, MD, Managing Director, MPM Capital  
Mary Szela, MBA, Senior Vice President, Pharmaceutical Operations, Abbott Laboratories  
Santosh Vetticaden, MD, PhD, CMO, ADVENTRX Pharmaceuticals  
Nancy Wetherbee, MBA, ORBIT Director, Tufts Medical Center  
Steven Zelenkofske, DO, FACC, CMO & Senior Vice President, Clinical and Medical Affairs, Regado Bioscience

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.

< back to medical news

For any corrections of factual information, or to contact the editors please use our feedback form.

Send your press releases to